CAPriCORN Current Studies


Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE)

Status: Data Analysis

The purpose of ADAPTABLE is to compare the effectiveness of two daily doses of aspirin widely used to prevent heart attacks and strokes in individuals living with heart disease.  What we will learn from the ADAPTABLE study will improve care and outcomes for patients with heart disease and could prevent as many as 88,800 deaths per year around the world.

Rush principal investigator: Raj C. Shah, MD; R. Jeffery Snell, MD


Precision Medicine Initiative (PMI)

 Status: Recruitment

This research initiative is a groundbreaking approach to disease prevention and treatment based on individual differences in environment, genes, and lifestyle. The goal of this study is to engage a group of 1 million research participants who will share biological samples, genetic data and diet/lifestyle information, all linked to their electronic health records. This data will allow researchers to develop more precise treatments for many diseases and health conditions.

Rush principal investigator: Raj C. Shah, MD


MINT logo

Myocardial Ischemia and Transfusion (MINT)

Status: Recruitment

The primary purpose of this research is to study how blood transfusions can affect recovery from a heart attack.

Rush principal investigator: Raj C. Shah, MD


PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)

Status: Recruitment

PREVENTABLE is one of the largest research studies in older adults. We aim to learn if taking a statin, a commonly used drug to lower cholesterol, could help older adults live well for longer by preventing dementia, disability, or heart disease. The benefits of taking statins for older adults without heart disease are not fully understood. Results from PREVENTABLE will help us learn if taking a statin is helpful for older adults.

Rush principal investigator: Raj C. Shah, MD

Healthcare Worker Exposure Response & Outcomes (HERO) Registry

Status: Recruitment 

The HERO research program wants to answer crucial questions about the impact of COVID-19 on you, your colleagues, family, and friends. The registry aims to build a community of workers in healthcare who better understand the effects of the pandemic on the front line. Registry members will have the opportunity to participate in research to generate evidence to improve the health and wellbeing of individuals working in the health care setting.

CAPriCORN Cohort Studies

CAPriCORN Anemia Survey

Status: data entry

The purpose of this study is to understand whether blood transfusions help people with a low blood count have more energy.

Rush principal investigator:  Jisu Kim, MD

CAPriCORN Asthma Survey

Status: data analysis

The purpose of this study is to determine how people are affected by asthma and other health conditions.

Rush principal Investigator:  Christopher Codispoti, MDSindhura Bandi, MD

Characterization of CAPriCORN Sickle Cell Disease Population

Status: data entry

The purpose of this research study is to understand how sickle cell disease affects the everyday life of individuals with this health condition.

Rush principal investigator:  Lisa Boggio, MD

CAPriCORN Weight Survey

Status: data analysis

The purpose of this research study is to better understand overweight and obesity. Overweight and obesity are highly prevalent conditions, affecting more than two-thirds of U.S. adults. These conditions are associated an increased risk of illness including conditions such as type 2 diabetes, heart disease, and some cancers.

Rush principal investigator: Steven K. Rothschild, MD; Bradley Appelhans, PhD

Recurrent Clostridium difficile Infection (RCDI) Cohort Survey

Status: data analysis

The purpose of this study is to better understand how the various symptoms of this condition affect individuals lives.

Rush principal investigator: Michael Lin, MD, MPH

Contact us

For information on CAPriCORN at Rush, contact